Business Context and Reporting Period
This Form 6-K filing by Smith & Nephew plc is dated August 12, 2026. The report serves as a notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities (PDMRs) and persons closely associated with them, made in accordance with the UK Market Abuse Regulation.
Key Financial Metrics
The filing does not provide financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It is a regulatory disclosure regarding specific share transactions rather than a financial results report.
Material Changes and Transaction Details
The filing details the vesting of 2023 Performance Share Awards under the Smith & Nephew Global Share Plan 2020 on August 12, 2026. The transaction involved the following:
- Instrument: Smith & Nephew plc ordinary shares of USD 0.20 each (ISIN: GB0009223206).
- Transaction Type: Vesting of awards followed by the sale of shares to cover tax liabilities.
- Location: London Stock Exchange (XLON).
- Individual Transaction:
- Name: Rohit Kashyap (President, Advanced Wound Management and Global Commercial Operations).
- Price: £11.096264 per share.
- Total Volume Vested: 23,202 shares (including dividend equivalent shares).
- Disposition: 9,163 shares were sold to cover tax liabilities; 14,039 shares were retained.
Any remaining shares under the award that did not vest have lapsed.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, outlook, risks, contingencies, or unusual items beyond the standard regulatory disclosure of the share transaction.
Key Facts for Investor Verification
- Verify the share price of £11.096264 against the market price on August 12, 2026.
- Confirm the total number of shares vested (23,202) and the split between sold (9,163) and retained (14,039) for Rohit Kashyap.
- Note that this transaction was executed to cover tax liabilities arising from the vesting of performance share awards.